# Xiaoming Yang

> Xiaoming Yang is a Series A investor at Sinopharm Capital (Shanghai) backing Medical and Biopharma. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Sinopharm Capital](https://shizune.co/investors/profile/sinopharm-capital)
- Location: Shanghai, China
- Total investments: 1
- Last investment: May 2018
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/xiaomingyang0521

Xiaoming Yang is a Series A investor at Sinopharm Capital in Shanghai focused on Medical and Biopharma. Xiaoming Yang - Managing Director @ Sinopharm Capital

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biopharma | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Clinical Trials | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ansun BioPharma | Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of unique host-directed anti-viral. The company is committed to developing safe and effective immuno-biologic therapies to treat the most vulnerable patients. Its founders were ingenious virologists and molecular biologists who realized that targeting a virusis difficult due to the virus’s ability to mutate and avoid the treatment. This ability to mutate also enables the virus to evade vaccines. So instead of trying to hit a moving target, they developed an innovative new approach to fight respiratory viruses: they targeted the host instead of the virus.The company was founded in 2003 and is headquartered in San Diego, California. | $85M | Series A | May 14, 2018 |  |

1 of 1 investments shown.

## Co-investors
- [3E Bioventures](https://shizune.co/investors/profile/3e-bioventures) — VC Fund, 1 deal together
- [Lilly Asia Ventures](https://shizune.co/investors/profile/lilly-asia-ventures) — VC Fund, 1 deal together
- [LYFE Capital](https://shizune.co/investors/profile/lyfe-capital-2) — VC Fund, 1 deal together
- [Oceanpine Capital](https://shizune.co/investors/profile/oceanpine-capital) — VC Fund, 1 deal together
- [Viventures](https://shizune.co/investors/profile/viventures) — VC Fund, 1 deal together
- [YuanMing Capital](https://shizune.co/investors/profile/yuanming-capital) — VC Fund, 1 deal together

## About Sinopharm Capital

VC Fund · Shanghai, China

Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. It seeks to invest in China. Sinopharm Capital was founded in June 2012 and isbased in Shanghai, China.

5 contacts available at Sinopharm Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Aimin Wu | President | https://shizune.co/investors/profile/aimin-wu |
| Fei Jiang | Executive Vice-President | https://shizune.co/investors/profile/fei-jiang |
| Shengtao Zhu | Managing Director | https://shizune.co/investors/profile/shengtao-zhu |
| Xiaoming Yang | Managing Director | https://shizune.co/investors/profile/xiaoming-yang |
| Yong Kuang | Managing Director | https://shizune.co/investors/profile/yong-yong |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Xiaoming Yang invest in?

Xiaoming Yang invests primarily in Medical, Biopharma and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Xiaoming Yang last invest?

The most recent investment recorded for Xiaoming Yang closed in May 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co